Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-049398

President and CEO gave up 23,872 shares (to pay taxes)

  • President and CEO acquired 83,092 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Walker Neal President and CEO 2020-09-01 Option exercise +83,092 1,170,023 D: show line 1 in the form
Walker Neal President and CEO 2020-09-01 Shares withheld for taxes −23,872 $2.33 $55,622 1,146,151 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Walker Neal President and CEO 2020-09-01 Grant or award · Restricted stock units +83,092 83,092 D: show line 3 in the form
Walker Neal President and CEO 2020-09-01 Option exercise · Restricted stock units −83,092 0 D: show line 4 in the form
Loading xslF345X03/doc4.xml…